TEAD3 and melanoma: To further evaluate the role of TEAD3 in a more clinically relevant and immunocompetent microenvironment, we utilized the YUMMER1.7 syngeneic mouse model, which closely mimics key characteristics of human immunotherapy-resistant melanoma.